Epsidy develops MRI-compatible wearable garments that enhance patient comfort and exam efficiency, specifically targeting the underrepresentation of women in cardiovascular clinical trials. This technology addresses the diagnostic challenges of heart disease in both women and men, ensuring more accurate assessments and improved management of cardiac conditions.
Funding
Funding not disclosed
Founders
Product
Problem
Cardiovascular clinical trials often underrepresent women, leading to a gap in knowledge and understanding of women's specific cardiac conditions and potentially inadequate management of heart disease in women. Existing medical devices and clinical research are often male-centric, which can result in less accurate assessments for female patients.
Solution
Epsidy develops MRI-compatible wearable garments designed to enhance patient comfort and improve the efficiency of cardiovascular exams for both women and men. By addressing the challenges of diagnosing heart disease, particularly in women who are often underrepresented in clinical trials, Epsidy aims to ensure more accurate assessments and improved management of cardiac conditions. The wearable garment is designed to accommodate the chest structure of both men and women, offering a universal solution for enhanced cardiac imaging. This technology helps to bridge the knowledge gap in women's cardiovascular health and promotes more inclusive and effective clinical research.
Target Audience
The primary target audience includes public universities, medical device manufacturers, and clinical researchers involved in cardiovascular studies, with a particular focus on those aiming to improve the diagnosis and management of heart disease in women.
Features
- MRI-compatible wearable garment for enhanced patient comfort during cardiovascular exams.
- Design accommodates both male and female chest structures.
- Aims to improve the accuracy of cardiac assessments.
- Facilitates more inclusive clinical research by addressing the underrepresentation of women.